339 related articles for article (PubMed ID: 26697128)
1. Bypassing Mechanisms of Mitochondria-Mediated Cancer Stem Cells Resistance to Chemo- and Radiotherapy.
Lyakhovich A; Lleonart ME
Oxid Med Cell Longev; 2016; 2016():1716341. PubMed ID: 26697128
[TBL] [Abstract][Full Text] [Related]
2. Cancer stem cells: Road to therapeutic resistance and strategies to overcome resistance.
Makena MR; Ranjan A; Thirumala V; Reddy AP
Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165339. PubMed ID: 30481586
[TBL] [Abstract][Full Text] [Related]
3. Cancer stem cells: a potential target for cancer therapy.
Qiu H; Fang X; Luo Q; Ouyang G
Cell Mol Life Sci; 2015 Sep; 72(18):3411-24. PubMed ID: 25967289
[TBL] [Abstract][Full Text] [Related]
4. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
[TBL] [Abstract][Full Text] [Related]
5. Cancer stem cells, metabolism, and therapeutic significance.
Yang M; Liu P; Huang P
Tumour Biol; 2016 May; 37(5):5735-42. PubMed ID: 26864589
[TBL] [Abstract][Full Text] [Related]
6. Role of Nrf2 and mitochondria in cancer stem cells; in carcinogenesis, tumor progression, and chemoresistance.
Payandeh Z; Pirpour Tazehkand A; Barati G; Pouremamali F; Kahroba H; Baradaran B; Samadi N
Biochimie; 2020 Dec; 179():32-45. PubMed ID: 32946993
[TBL] [Abstract][Full Text] [Related]
7. The cancer stem-cell signaling network and resistance to therapy.
Carnero A; Garcia-Mayea Y; Mir C; Lorente J; Rubio IT; LLeonart ME
Cancer Treat Rev; 2016 Sep; 49():25-36. PubMed ID: 27434881
[TBL] [Abstract][Full Text] [Related]
8. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
[TBL] [Abstract][Full Text] [Related]
9. The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer.
Fernandez HR; Gadre SM; Tan M; Graham GT; Mosaoa R; Ongkeko MS; Kim KA; Riggins RB; Parasido E; Petrini I; Pacini S; Cheema A; Varghese R; Ressom HW; Zhang Y; Albanese C; Üren A; Paige M; Giaccone G; Avantaggiati ML
Cell Death Differ; 2018 Jul; 25(7):1239-1258. PubMed ID: 29651165
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem cell (CSC) resistance drivers.
Najafi M; Mortezaee K; Majidpoor J
Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
[TBL] [Abstract][Full Text] [Related]
11. Targeting autophagy in cancer stem cells as an anticancer therapy.
Lei Y; Zhang D; Yu J; Dong H; Zhang J; Yang S
Cancer Lett; 2017 May; 393():33-39. PubMed ID: 28216370
[TBL] [Abstract][Full Text] [Related]
12. Predominant factors influencing reactive oxygen species in cancer stem cells.
Soundararajan L; Warrier S; Dharmarajan A; Bhaskaran N
J Cell Biochem; 2024 Jan; 125(1):3-21. PubMed ID: 37997702
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cells and resistance to chemo and radio therapy.
Malik B; Nie D
Front Biosci (Elite Ed); 2012 Jan; 4(6):2142-9. PubMed ID: 22202026
[TBL] [Abstract][Full Text] [Related]
14. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
15. Drug Resistance Driven by Cancer Stem Cells and Their Niche.
Prieto-Vila M; Takahashi RU; Usuba W; Kohama I; Ochiya T
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194401
[TBL] [Abstract][Full Text] [Related]
16. Cancer Stem Cells: Root of the Evil.
Erkisa M; Karakas D; Ulukaya E
Crit Rev Oncog; 2019; 24(1):69-87. PubMed ID: 31679222
[TBL] [Abstract][Full Text] [Related]
17. The Roles of Cancer Stem Cells and Therapy Resistance in Colorectal Carcinoma.
Das PK; Islam F; Lam AK
Cells; 2020 Jun; 9(6):. PubMed ID: 32503256
[TBL] [Abstract][Full Text] [Related]
18. The molecular mechanisms underlying the therapeutic resistance of cancer stem cells.
Kim JK; Jeon HY; Kim H
Arch Pharm Res; 2015 Mar; 38(3):389-401. PubMed ID: 25502807
[TBL] [Abstract][Full Text] [Related]
19. Potential mechanisms of CD133 in cancer stem cells.
Jang JW; Song Y; Kim SH; Kim J; Seo HR
Life Sci; 2017 Sep; 184():25-29. PubMed ID: 28697984
[TBL] [Abstract][Full Text] [Related]
20. Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.
Walcher L; Kistenmacher AK; Suo H; Kitte R; Dluczek S; Strauß A; Blaudszun AR; Yevsa T; Fricke S; Kossatz-Boehlert U
Front Immunol; 2020; 11():1280. PubMed ID: 32849491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
